<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-23774" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Irritable Bowel Syndrome</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Patel</surname>
            <given-names>Nicolas</given-names>
          </name>
          <aff>NYU School of Medicine/NYU Langone</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Shackelford</surname>
            <given-names>Karen B.</given-names>
          </name>
          <aff>University of Mississippi School of Medicine</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Nicolas Patel declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Karen Shackelford declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>30</day>
          <month>10</month>
          <year>2022</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-23774.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Irritable bowel syndrome (IBS) is one of the most commonly diagnosed gastrointestinal diseases. IBS, in the absence of any other causative disease, is defined as the presence of abdominal pain or discomfort with altered bowel habits. Diagnosis of IBS has evolved since its first discovery, and today the Rome IV diagnostic criteria are used to diagnose IBS. Depending on the subclass of IBS, symptoms can be managed by a variety of medications and nonpharmaceutical agents. Nonetheless, IBS treatment should be individualized, and a significant factor in management remains a strong patient-clinician relationship. This activity reviews the evaluation and management of and highlights the role of the interprofessional team in the recognition and management of this condition.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Describe the recommended management of irritable bowel syndrome (IBS).</p></list-item><list-item><p>Outline the typical presentation for a patient with irritable bowel syndrome (IBS).</p></list-item><list-item><p>Review the pathophysiology of irritable bowel syndrome (IBS).</p></list-item><list-item><p>Explain the interprofessional team strategies for improving care coordination and communication regarding the management of patients with IBS.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=23774&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=23774">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-23774.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Irritable bowel&#x000a0;syndrome (IBS) is one of the most commonly diagnosed gastrointestinal diseases. IBS, in the absence of any other causative disease, is defined as the presence of&#x000a0;abdominal pain or discomfort with altered bowel habits. Diagnosis of IBS has evolved since its first discovery, and today the Rome IV diagnostic criteria are used to diagnose IBS. Depending on the subclass of IBS, symptoms can&#x000a0;be managed&#x000a0;by a variety of&#x000a0;medications&#x000a0;and nonpharmaceutical agents. Nonetheless,&#x000a0;IBS treatment should be&#x000a0;individualized, and a significant factor in management remains a strong patient-physician relationship.<xref ref-type="bibr" rid="article-23774.r1">[1]</xref></p>
      </sec>
      <sec id="article-23774.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>The etiology of IBS is broad and not clearly&#x000a0;understood. However, as below in the pathophysiology section, motility, visceral sensation, brain-gut interaction, and psychosocial distress can all play a role in the development of IBS.</p>
      </sec>
      <sec id="article-23774.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>Nearly 12 percent of patients seek medical care in primary care practices for IBS related complaints.<xref ref-type="bibr" rid="article-23774.r1">[1]</xref><xref ref-type="bibr" rid="article-23774.r2">[2]</xref> Studies have demonstrated that the prevalence of IBS ranges between ten and fifteen percent; however,&#x000a0;the majority of&#x000a0;these patients do not seek medical care.<xref ref-type="bibr" rid="article-23774.r1">[1]</xref> IBS is most prevalent in South America at approximately 21 percent and least prevalent in Southeast Asia at 7 percent.<xref ref-type="bibr" rid="article-23774.r3">[3]</xref><xref ref-type="bibr" rid="article-23774.r4">[4]</xref> In the United States, Canada, and Isreal, IBS symptoms are 1.5 to 2 times more prevalent among women than men.<xref ref-type="bibr" rid="article-23774.r5">[5]</xref> Moreover, women are more likely to report abdominal pain and constipation, whereas men are more likely to report diarrhea.<xref ref-type="bibr" rid="article-23774.r5">[5]</xref> The prevalence of IBS also decreases with age.<xref ref-type="bibr" rid="article-23774.r3">[3]</xref> IBS can also be broken down into more specific diagnoses, which include IBS with diarrhea (IBS-D), IBS with constipation (IBS-C), and IBS with mixed bowel patterns (IBS-M). The prevalence of these three diagnoses differs in the United States versus Europe. In the United States, there is an equal distribution of these diagnoses, whereas, in Europe, IBS-C or IBS-M can be more prevalent.<xref ref-type="bibr" rid="article-23774.r6">[6]</xref></p>
      </sec>
      <sec id="article-23774.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>The pathophysiology of IBS is broad and includes abnormalities involving motility, visceral sensation, brain-gut interaction, and psychosocial distress.<xref ref-type="bibr" rid="article-23774.r3">[3]</xref> One of these can usually be demonstrated in the&#x000a0;majority of IBS patients; however, not all symptoms can be attributed to them.<xref ref-type="bibr" rid="article-23774.r3">[3]</xref> Recent studies have also shown altered gut immune activation and intestinal and colonic microbiome are associated with IBS<xref ref-type="bibr" rid="article-23774.r3">[3]</xref><xref ref-type="bibr" rid="article-23774.r7">[7]</xref><xref ref-type="bibr" rid="article-23774.r8">[8]</xref>. Environmental contributors&#x000a0;to IBS include&#x000a0;early life stressors, food intolerance, antibiotics, and enteric infections.<xref ref-type="bibr" rid="article-23774.r3">[3]</xref> Patients often complain that IBS symptoms are related to food intake. However, a true food allergen has a limited contribution to IBS.<xref ref-type="bibr" rid="article-23774.r3">[3]</xref><xref ref-type="bibr" rid="article-23774.r9">[9]</xref></p>
      </sec>
      <sec id="article-23774.s6" sec-type="Histopathology">
        <title>Histopathology</title>
        <p>Histopathology examination&#x000a0;of the intestinal mucosa in those with IBS can show chronic inflammatory cells, mast cells, enteroendocrine cells, and enteric nerves.<xref ref-type="bibr" rid="article-23774.r10">[10]</xref>. IBS-D is typically associated with a greater increase in mucosal T-lymphocytes than IBS-C.<xref ref-type="bibr" rid="article-23774.r10">[10]</xref><xref ref-type="bibr" rid="article-23774.r11">[11]</xref> Moreover, there can be an increased number of nerve fibers that stain positive for neuron-specific enolase, substance P, and 5-HT.<xref ref-type="bibr" rid="article-23774.r10">[10]</xref><xref ref-type="bibr" rid="article-23774.r12">[12]</xref> There also appears to be a&#x000a0;significantly&#x000a0;increased density of nerve fibers around mast cells.<xref ref-type="bibr" rid="article-23774.r10">[10]</xref><xref ref-type="bibr" rid="article-23774.r12">[12]</xref></p>
      </sec>
      <sec id="article-23774.s7" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>IBS typically consists of abdominal pain or discomfort, altered bowel habits along with constipation, diarrhea, or both. Other complaints in patients with IBS include bloating, distention, symptoms brought on by food intake, and a change in pain location and stool pattern with time.<xref ref-type="bibr" rid="article-23774.r3">[3]</xref>. Concerning features would include onset after the age of 50 years old, severe or progressive symptoms, unexplained weight loss, nocturnal diarrhea, rectal bleeding, iron deficiency anemia, or a family history of organic gastrointestinal diseases such as colon cancer, celiac disease, or inflammatory bowel disease.<xref ref-type="bibr" rid="article-23774.r3">[3]</xref> Additional history that would be important would include travel and social history.</p>
        <p>The Rome IV criteria&#x000a0;are&#x000a0;used to diagnose IBD, which requires at least 3 days a month in the last 3 months associated with 2 or more of&#x000a0;the following: improvement in abdominal pain or discomfort with defecation, onset associated with a change in frequency of stool, and/or an onset accompanied by a change in form or appearance of stool<xref ref-type="bibr" rid="article-23774.r3">[3]</xref>.</p>
      </sec>
      <sec id="article-23774.s8" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>If no alarm findings exist&#x000a0;(weight loss, hematochezia, iron deficiency),&#x000a0;routine diagnostic testing is not recommended.<xref ref-type="bibr" rid="article-23774.r1">[1]</xref> If symptoms are not typical of IBS or alarm symptoms are present, then a complete blood cell count, comprehensive metabolic panel, inflammatory markers such as erythrocyte sedimentation rate or C-reactive protein, and thyroid stimulating hormone level should be checked.<xref ref-type="bibr" rid="article-23774.r1">[1]</xref> If diarrhea is predominant, fecal leukocytes and stool tests for Clostridium&#x000a0;difficile, Giardia, and Cryptosporidium, when appropriate, should be ordered.<xref ref-type="bibr" rid="article-23774.r1">[1]</xref> Testing for celiac disease may be needed&#x000a0;as well, and a tissue transglutaminase or TTG-IgA can be obtained.<xref ref-type="bibr" rid="article-23774.r1">[1]</xref> A colonoscopy may be beneficial when there is a family history of inflammatory bowel disease, colon cancer, or alarm symptoms.<xref ref-type="bibr" rid="article-23774.r1">[1]</xref> If the patient has diarrhea, random biopsies should be done on colonoscopy.<xref ref-type="bibr" rid="article-23774.r1">[1]</xref></p>
      </sec>
      <sec id="article-23774.s9" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>One of the most important goals in the management of IBS patients is to develop a trusting patient-physician relationship by actively&#x000a0;listening, showing empathy, and setting realistic expectations for treatment.<xref ref-type="bibr" rid="article-23774.r3">[3]</xref><xref ref-type="bibr" rid="article-23774.r13">[13]</xref> IBS is a symptom-based disorder, and thus treatment goals are aimed at resolving symptoms such as pain, bloating, cramping, and diarrhea or constipation.<xref ref-type="bibr" rid="article-23774.r3">[3]</xref> For constipation, fiber supplements and laxatives can be helpful whereas, in those with diarrhea, medications such as loperamide or probiotics can be helpful.<xref ref-type="bibr" rid="article-23774.r3">[3]</xref> Moreover,&#x000a0;increased physical activity&#x000a0;can increase colonic transit time and improve symptoms.<xref ref-type="bibr" rid="article-23774.r3">[3]</xref><xref ref-type="bibr" rid="article-23774.r14">[14]</xref> Patients also often associate food intake with IBS symptoms. Foods such as wheat products, onions, fruits, vegetables, sorbitol, and some dairy can include short-chain, poorly absorbed, highly fermentable carbohydrates,&#x000a0;which are known as FODMAPs. FODMAPs&#x000a0;have&#x000a0;been associated with increased gastrointestinal symptoms in IBS patients.<xref ref-type="bibr" rid="article-23774.r3">[3]</xref> Patients with constant and chronic abdominal symptoms oftentimes can have a response to low dose tricyclic antidepressants (TCAs) or serotonin reuptake inhibitors (SSRIs).<xref ref-type="bibr" rid="article-23774.r1">[1]</xref>&#x000a0;Alosetron can be used to treat IBS-D in females but can cause ischemic colitis.</p>
        <p>Rifaximin is a nonabsorbable broad-spectrum antibiotic sometimes used to treat patients with irritable bowel syndrome.&#x000a0;Patients with irritable bowel syndrome who take rifaximin have less abdominal pain and diarrhea. The effectiveness of rifaximin in patients with IBS is used as evidence to support the idea that bacterial overgrowth plays a role in the etiology of IBS.</p>
      </sec>
      <sec id="article-23774.s10" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>The differential diagnosis of IBS is broad and ultimately depends on whether the patient has predominant diarrhea or constipation.&#x000a0; If a patient has IBS with diarrhea, the differentials includes lactose intolerance, caffeine intake, alcohol intake, gastrointestinal infections (Giardia, Amoeba, HIV), inflammatory bowel disease, medication-induced diarrhea (antibiotic use, proton pump inhibitor, nonsteroidal anti-inflammatory drugs, ACE inhibitor, chemotherapy), celiac disease, malignancies, colorectal cancer, hyperthyroidism, VIPoma, and ischemic colitis.<xref ref-type="bibr" rid="article-23774.r15">[15]</xref> If constipation is the predominant symptoms, then the differentials can include inadequate fiber intake, immobility,&#x000a0;Parkinson's disease, multiple sclerosis, spinal injury, diabetes,&#x000a0;hypothyroidism, hypercalcemia,&#x000a0;medication-induced (opiates, calcium-channel blockers, antidepressants, clonidine), malignancies, bowel obstruction, endometriosis, and diverticular disease.&#x000a0;If a patient's history indicates one of these diseases, then appropriate lab testing should&#x000a0;be pursued.<xref ref-type="bibr" rid="article-23774.r15">[15]</xref></p>
      </sec>
      <sec id="article-23774.s11" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>IBS has a good prognosis, and&#x000a0;the diagnosis is unlikely to change on follow-up.<xref ref-type="bibr" rid="article-23774.r16">[16]</xref> The use of ambulatory health services by IBS patients can be reduced if a positive physician-patient interaction is developed.<xref ref-type="bibr" rid="article-23774.r16">[16]</xref></p>
      </sec>
      <sec id="article-23774.s12" sec-type="Consultations">
        <title>Consultations</title>
        <p>Important consults include a gastroenterologist and a nutritionist. Gastroenterologists often&#x000a0;sub-specialize&#x000a0;in IBS care and are invaluable&#x000a0;members of the treatment team. A gastroenterologist&#x000a0;can tailor treatment plans for the patient and are also likely to be more aware of advancements in the field of&#x000a0;IBS. Given that patients often believe certain&#x000a0;food intake&#x000a0;is&#x000a0;associated with their symptoms, and the findings of FODMAPs association with IBS, nutritionists are vital to providing dietary recommendations for the patient.</p>
      </sec>
      <sec id="article-23774.s13" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>If a patient has concerns about abdominal pain, bloating, cramping, and changes in bowel habits, a visit to a primary care physician is advised. If IBS is diagnosed, a gastroenterology consultation will be needed as they can guide management and treatment.</p>
      </sec>
      <sec id="article-23774.s14" sec-type="Pearls and Other Issues">
        <title>Pearls and Other Issues</title>
        <p>IBS can be sub-classified into IBS-C, IBS-D, or IBS-M. Although some treatments are the same between the groups, each subclassification is&#x000a0;unique and has different treatments focused on the different symptomatologies.&#x000a0;</p>
      </sec>
      <sec id="article-23774.s15" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>IBS can be a very disabling syndrome for patients, and it has&#x000a0;been shown to be a very&#x000a0;common reason for seeking medical attention. It is vital that there is an interprofessional&#x000a0;approach&#x000a0;when it comes to the care of these patients as it can improve the quality of life, reduce medications needed, and manage the symptoms of IBS much better.<xref ref-type="bibr" rid="article-23774.r17">[17]</xref>&#x000a0;The team can include primary care providers, gastroenterologists, specialty-trained nurses, and pharmacists. Nurses provide education to patients and their families, monitor response to treatment, and report patient status to the team. Pharmacists review prescribed medications for dose and interactions, as well as review usage and side effects with patients. [Level 5]</p>
      </sec>
      <sec id="article-23774.s16">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=23774&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=23774">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/gut-health/irritable-bowel-syndrome/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=23774">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/23774/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=23774">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-23774.s17">
        <title>References</title>
        <ref id="article-23774.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Occhipinti</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Smith</surname>
                <given-names>JW</given-names>
              </name>
            </person-group>
            <article-title>Irritable bowel syndrome: a review and update.</article-title>
            <source>Clin Colon Rectal Surg</source>
            <year>2012</year>
            <month>Mar</month>
            <volume>25</volume>
            <issue>1</issue>
            <fpage>46</fpage>
            <page-range>46-52</page-range>
            <pub-id pub-id-type="pmid">23449495</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23774.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Drossman</surname>
                <given-names>DA</given-names>
              </name>
              <name>
                <surname>Camilleri</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Mayer</surname>
                <given-names>EA</given-names>
              </name>
              <name>
                <surname>Whitehead</surname>
                <given-names>WE</given-names>
              </name>
            </person-group>
            <article-title>AGA technical review on irritable bowel syndrome.</article-title>
            <source>Gastroenterology</source>
            <year>2002</year>
            <month>Dec</month>
            <volume>123</volume>
            <issue>6</issue>
            <fpage>2108</fpage>
            <page-range>2108-31</page-range>
            <pub-id pub-id-type="pmid">12454866</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23774.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chey</surname>
                <given-names>WD</given-names>
              </name>
              <name>
                <surname>Kurlander</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Eswaran</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Irritable bowel syndrome: a clinical review.</article-title>
            <source>JAMA</source>
            <year>2015</year>
            <month>Mar</month>
            <day>03</day>
            <volume>313</volume>
            <issue>9</issue>
            <fpage>949</fpage>
            <page-range>949-58</page-range>
            <pub-id pub-id-type="pmid">25734736</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23774.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lovell</surname>
                <given-names>RM</given-names>
              </name>
              <name>
                <surname>Ford</surname>
                <given-names>AC</given-names>
              </name>
            </person-group>
            <article-title>Global prevalence of and risk factors for irritable bowel syndrome: a meta-analysis.</article-title>
            <source>Clin Gastroenterol Hepatol</source>
            <year>2012</year>
            <month>Jul</month>
            <volume>10</volume>
            <issue>7</issue>
            <fpage>712</fpage>
            <page-range>712-721.e4</page-range>
            <pub-id pub-id-type="pmid">22426087</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23774.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lovell</surname>
                <given-names>RM</given-names>
              </name>
              <name>
                <surname>Ford</surname>
                <given-names>AC</given-names>
              </name>
            </person-group>
            <article-title>Effect of gender on prevalence of irritable bowel syndrome in the community: systematic review and meta-analysis.</article-title>
            <source>Am J Gastroenterol</source>
            <year>2012</year>
            <month>Jul</month>
            <volume>107</volume>
            <issue>7</issue>
            <fpage>991</fpage>
            <page-range>991-1000</page-range>
            <pub-id pub-id-type="pmid">22613905</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23774.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Guilera</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Balboa</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Mearin</surname>
                <given-names>F</given-names>
              </name>
            </person-group>
            <article-title>Bowel habit subtypes and temporal patterns in irritable bowel syndrome: systematic review.</article-title>
            <source>Am J Gastroenterol</source>
            <year>2005</year>
            <month>May</month>
            <volume>100</volume>
            <issue>5</issue>
            <fpage>1174</fpage>
            <page-range>1174-84</page-range>
            <pub-id pub-id-type="pmid">15842596</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23774.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Simr&#x000e9;n</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Barbara</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Flint</surname>
                <given-names>HJ</given-names>
              </name>
              <name>
                <surname>Spiegel</surname>
                <given-names>BM</given-names>
              </name>
              <name>
                <surname>Spiller</surname>
                <given-names>RC</given-names>
              </name>
              <name>
                <surname>Vanner</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Verdu</surname>
                <given-names>EF</given-names>
              </name>
              <name>
                <surname>Whorwell</surname>
                <given-names>PJ</given-names>
              </name>
              <name>
                <surname>Zoetendal</surname>
                <given-names>EG</given-names>
              </name>
              <collab>Rome Foundation Committee</collab>
            </person-group>
            <article-title>Intestinal microbiota in functional bowel disorders: a Rome foundation report.</article-title>
            <source>Gut</source>
            <year>2013</year>
            <month>Jan</month>
            <volume>62</volume>
            <issue>1</issue>
            <fpage>159</fpage>
            <page-range>159-76</page-range>
            <pub-id pub-id-type="pmid">22730468</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23774.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Dupont</surname>
                <given-names>HL</given-names>
              </name>
            </person-group>
            <article-title>Review article: evidence for the role of gut microbiota in irritable bowel syndrome and its potential influence on therapeutic targets.</article-title>
            <source>Aliment Pharmacol Ther</source>
            <year>2014</year>
            <month>May</month>
            <volume>39</volume>
            <issue>10</issue>
            <fpage>1033</fpage>
            <page-range>1033-42</page-range>
            <pub-id pub-id-type="pmid">24665829</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23774.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Park</surname>
                <given-names>MI</given-names>
              </name>
              <name>
                <surname>Camilleri</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Is there a role of food allergy in irritable bowel syndrome and functional dyspepsia? A systematic review.</article-title>
            <source>Neurogastroenterol Motil</source>
            <year>2006</year>
            <month>Aug</month>
            <volume>18</volume>
            <issue>8</issue>
            <fpage>595</fpage>
            <page-range>595-607</page-range>
            <pub-id pub-id-type="pmid">16918724</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23774.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kirsch</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Riddell</surname>
                <given-names>RH</given-names>
              </name>
            </person-group>
            <article-title>Histopathological alterations in irritable bowel syndrome.</article-title>
            <source>Mod Pathol</source>
            <year>2006</year>
            <month>Dec</month>
            <volume>19</volume>
            <issue>12</issue>
            <fpage>1638</fpage>
            <page-range>1638-45</page-range>
            <pub-id pub-id-type="pmid">17013373</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23774.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chadwick</surname>
                <given-names>VS</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Shu</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Paulus</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Bethwaite</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Tie</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Wilson</surname>
                <given-names>I</given-names>
              </name>
            </person-group>
            <article-title>Activation of the mucosal immune system in irritable bowel syndrome.</article-title>
            <source>Gastroenterology</source>
            <year>2002</year>
            <month>Jun</month>
            <volume>122</volume>
            <issue>7</issue>
            <fpage>1778</fpage>
            <page-range>1778-83</page-range>
            <pub-id pub-id-type="pmid">12055584</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23774.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wang</surname>
                <given-names>LH</given-names>
              </name>
              <name>
                <surname>Fang</surname>
                <given-names>XC</given-names>
              </name>
              <name>
                <surname>Pan</surname>
                <given-names>GZ</given-names>
              </name>
            </person-group>
            <article-title>Bacillary dysentery as a causative factor of irritable bowel syndrome and its pathogenesis.</article-title>
            <source>Gut</source>
            <year>2004</year>
            <month>Aug</month>
            <volume>53</volume>
            <issue>8</issue>
            <fpage>1096</fpage>
            <page-range>1096-101</page-range>
            <pub-id pub-id-type="pmid">15247174</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23774.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Drossman</surname>
                <given-names>DA</given-names>
              </name>
            </person-group>
            <article-title>2012 David Sun lecture: helping your patient by helping yourself--how to improve the patient-physician relationship by optimizing communication skills.</article-title>
            <source>Am J Gastroenterol</source>
            <year>2013</year>
            <month>Apr</month>
            <volume>108</volume>
            <issue>4</issue>
            <fpage>521</fpage>
            <page-range>521-8</page-range>
            <pub-id pub-id-type="pmid">23511457</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23774.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Song</surname>
                <given-names>BK</given-names>
              </name>
              <name>
                <surname>Cho</surname>
                <given-names>KO</given-names>
              </name>
              <name>
                <surname>Jo</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Oh</surname>
                <given-names>JW</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>YS</given-names>
              </name>
            </person-group>
            <article-title>Colon transit time according to physical activity level in adults.</article-title>
            <source>J Neurogastroenterol Motil</source>
            <year>2012</year>
            <month>Jan</month>
            <volume>18</volume>
            <issue>1</issue>
            <fpage>64</fpage>
            <page-range>64-9</page-range>
            <pub-id pub-id-type="pmid">22323989</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23774.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lucak</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Diagnosing irritable bowel syndrome: what's too much, what's enough?</article-title>
            <source>MedGenMed</source>
            <year>2004</year>
            <month>Mar</month>
            <day>12</day>
            <volume>6</volume>
            <issue>1</issue>
            <fpage>17</fpage>
            <pub-id pub-id-type="pmid">15208529</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23774.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Owens</surname>
                <given-names>DM</given-names>
              </name>
              <name>
                <surname>Nelson</surname>
                <given-names>DK</given-names>
              </name>
              <name>
                <surname>Talley</surname>
                <given-names>NJ</given-names>
              </name>
            </person-group>
            <article-title>The irritable bowel syndrome: long-term prognosis and the physician-patient interaction.</article-title>
            <source>Ann Intern Med</source>
            <year>1995</year>
            <month>Jan</month>
            <day>15</day>
            <volume>122</volume>
            <issue>2</issue>
            <fpage>107</fpage>
            <page-range>107-12</page-range>
            <pub-id pub-id-type="pmid">7992984</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23774.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Shani-Zur</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Wolkomir</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>[Irritable Bowel Syndrome treatment: a multidisciplinary approach].</article-title>
            <source>Harefuah</source>
            <year>2015</year>
            <month>Jan</month>
            <volume>154</volume>
            <issue>1</issue>
            <fpage>52</fpage>
            <page-range>52-5, 66</page-range>
            <pub-id pub-id-type="pmid">25796677</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
